With years of experience in the Pharmaceutical and life science sectors, CD Bioparticles announces the launch of its new line ...

Paclitaxel is under clinical development by InnoUp Farma and currently in Phase I for Solid Tumor. According to GlobalData, Phase I drugs for Solid Tumor have a 69% phase transition success rate (PTSR ...

Liposomes have attractive biological properties, including general biocompatibility, biodegradability, isolation of drugs from the surrounding environment and the ability to entrap both ...

Researchers develop inhalable nanoparticles for lung cancer treatment inspired by mussels New technology transforms lung ...

Request To Download Free Sample of This Strategic Report @ Key Trends in the Vietnam Silver Nanoparticles Market: Silver nanoparticles are known for their antimicrobial properties, making them ...

The therapeutic candidate is under development for the treatment of liver fibrosis and KRAS-driven liver cancer. It is an antisense RNAi oligonucleotide delivered through lipid-nanoparticles and is ...

Further proof of great versatility of Altamira’s platform for extrahepatic RNA deliveryCircular mRNA significantly increasing ...

"We are very excited about the potential for CycloPhore as circular mRNA has been attracting great interest in drug development thanks to enhanced ... is developing and supplying peptide-based ...

Four MIT faculty members are among 23 world-class researchers who have been awarded the nation's highest honors for scientists and innovators, the ...

RenovoRx, Inc. ("RenovoRx" or the "Company") (Nasdaq: RNXT), a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath®, a novel, FDA-cleared delivery system, ...